ARCHIVES

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

This article is from The Cancer Letter archive.

Vol. 33 No. 15 | April 20, 2007

Download PDF Visit The Full Archive

Related Articles

James Doroshow Named NCI Deputy Director, Clinical Research

June 10, 2011

Communication Is Key To Clinical Trial Enrollment

June 30, 2006

USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears

March 30, 2012

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981

DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy

May 27, 1988

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

October 15, 1982